Funding for this research was provided by:
United States Agency for International Development (AID-621-LA-13-00001)
Received: 25 February 2017
Accepted: 4 October 2017
First Online: 26 October 2017
Ethics approval and consent to participate
: The trial protocol (version 1, 25 September 2016) was reviewed and approved by the National Institute for Medical Research, Tanzania, Dar es Salaam, Tanzania (NIMR/HQ/R.8a/Vol.IX/2198, 16 May 2016) and the Western Institutional Review Board, Puyallup, WA, USA (study 1163682, 27 September 2016). The two ethical approvals listed above cover all seven study sites. All participants will undergo informed consent procedures, and no participant will be enrolled until the study staff has obtained legally effective (signed or witnessed) informed consent. All medical procedures in this trial are under the oversight of the Tanzania Ministry of Health, Community Development, Gender, Elderly, and Children.
: Consent for publication is not applicable. All participants will be assigned a trial participant number. Participants will not be identified by name on any documents or in connection with any data that leave the study sites, nor will they be reported by name in any report or publication resulting from data collected in this study.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.